Request for Covid-19 Impact Assessment of this Report

Diagnostic and Biotech

Global Chemotherapy Sales Market Report 2016

  • QYR706438
  • 125 Pages
  • September 2016
  • Diagnostic and Biotech
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Chemotherapy

Revenue, means the sales value of Chemotherapy

This report studies sales (consumption) of Chemotherapy in Global market, especially in USA, China, Europe, Japan, India and Southeast Asia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

Pfizer Inc. (USA)

Abbott Laboratories (USA)

Genentech Inc. (USA)

GlaxoSmithKline Plc (UK)

Immunomedics, Inc. (USA)

Indevus Pharmaceuticals Inc. (USA)

Novartis AG (Switzerland)

OSI Pharmaceuticals, Inc. (USA)

Paladin Labs Inc. (Canada)

ALZA Corporation (USA)

Amgen Inc. (USA)

AstraZeneca PLC (UK)

Medimmune, LLC (USA)

Bristol-Myers Squibb Company (USA)

Cell Genesys Inc. (USA)

Dendreon Corporation (USA)

EUSA Pharma, (USA) Inc. (USA)

F. Hoffmann-La Roche Ltd. (Switzerland)

Progenics Pharmaceuticals, Inc. (USA)

Sanofi-Aventis SA (France)

Spectrum Pharmaceuticals, Inc. (USA)

Takeda Pharmaceutical Company Limited (Japan)

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Chemotherapy in these regions, from 2011 to 2021 (forecast), like

USA

China

Europe

Japan

India

Southeast Asia

Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into

Type I

Type II

Type III

Split by applications, this report focuses on sales, market share and growth rate of Chemotherapy in each application, can be divided into

Application 1

Application 2

Application 3

Table of Contents

Global Chemotherapy Sales Market Report 2016

1 Chemotherapy Overview

1.1 Product Overview and Scope of Chemotherapy

1.2 Classification of Chemotherapy

1.2.1 Type I

1.2.2 Type II

1.2.3 Type III

1.3 Application of Chemotherapy

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

1.4 Chemotherapy Market by Regions

1.4.1 USA Status and Prospect (2011-2021)

1.4.2 China Status and Prospect (2011-2021)

1.4.3 Europe Status and Prospect (2011-2021)

1.4.4 Japan Status and Prospect (2011-2021)

1.4.5 India Status and Prospect (2011-2021)

1.4.6 Southeast Asia Status and Prospect (2011-2021)

1.5 Global Market Size (Value and Volume) of Chemotherapy (2011-2021)

1.5.1 Global Chemotherapy Sales and Growth Rate (2011-2021)

1.5.2 Global Chemotherapy Revenue and Growth Rate (2011-2021)

2 Global Chemotherapy Competition by Manufacturers, Type and Application

2.1 Global Chemotherapy Market Competition by Manufacturers

2.1.1 Global Chemotherapy Sales and Market Share of Key Manufacturers (2011-2016)

2.1.2 Global Chemotherapy Revenue and Share by Manufacturers (2011-2016)

2.2 Global Chemotherapy (Volume and Value) by Type

2.2.1 Global Chemotherapy Sales and Market Share by Type (2011-2016)

2.2.2 Global Chemotherapy Revenue and Market Share by Type (2011-2016)

2.3 Global Chemotherapy (Volume and Value) by Regions

2.3.1 Global Chemotherapy Sales and Market Share by Regions (2011-2016)

2.3.2 Global Chemotherapy Revenue and Market Share by Regions (2011-2016)

2.4 Global Chemotherapy (Volume) by Application

3 USA Chemotherapy (Volume, Value and Sales Price)

3.1 USA Chemotherapy Sales and Value (2011-2016)

3.1.1 USA Chemotherapy Sales and Growth Rate (2011-2016)

3.1.2 USA Chemotherapy Revenue and Growth Rate (2011-2016)

3.1.3 USA Chemotherapy Sales Price Trend (2011-2016)

3.2 USA Chemotherapy Sales and Market Share by Manufacturers

3.3 USA Chemotherapy Sales and Market Share by Type

3.4 USA Chemotherapy Sales and Market Share by Application

4 China Chemotherapy (Volume, Value and Sales Price)

4.1 China Chemotherapy Sales and Value (2011-2016)

4.1.1 China Chemotherapy Sales and Growth Rate (2011-2016)

4.1.2 China Chemotherapy Revenue and Growth Rate (2011-2016)

4.1.3 China Chemotherapy Sales Price Trend (2011-2016)

4.2 China Chemotherapy Sales and Market Share by Manufacturers

4.3 China Chemotherapy Sales and Market Share by Type

4.4 China Chemotherapy Sales and Market Share by Application

5 Europe Chemotherapy (Volume, Value and Sales Price)

5.1 Europe Chemotherapy Sales and Value (2011-2016)

5.1.1 Europe Chemotherapy Sales and Growth Rate (2011-2016)

5.1.2 Europe Chemotherapy Revenue and Growth Rate (2011-2016)

5.1.3 Europe Chemotherapy Sales Price Trend (2011-2016)

5.2 Europe Chemotherapy Sales and Market Share by Manufacturers

5.3 Europe Chemotherapy Sales and Market Share by Type

5.4 Europe Chemotherapy Sales and Market Share by Application

6 Japan Chemotherapy (Volume, Value and Sales Price)

6.1 Japan Chemotherapy Sales and Value (2011-2016)

6.1.1 Japan Chemotherapy Sales and Growth Rate (2011-2016)

6.1.2 Japan Chemotherapy Revenue and Growth Rate (2011-2016)

6.1.3 Japan Chemotherapy Sales Price Trend (2011-2016)

6.2 Japan Chemotherapy Sales and Market Share by Manufacturers

6.3 Japan Chemotherapy Sales and Market Share by Type

6.4 Japan Chemotherapy Sales and Market Share by Application

7 India Chemotherapy (Volume, Value and Sales Price)

7.1 India Chemotherapy Sales and Value (2011-2016)

7.1.1 India Chemotherapy Sales and Growth Rate (2011-2016)

7.1.2 India Chemotherapy Revenue and Growth Rate (2011-2016)

7.1.3 India Chemotherapy Sales Price Trend (2011-2016)

7.2 India Chemotherapy Sales and Market Share by Manufacturers

7.3 India Chemotherapy Sales and Market Share by Type

7.4 India Chemotherapy Sales and Market Share by Application

8 Southeast Asia Chemotherapy (Volume, Value and Sales Price)

8.1 Southeast Asia Chemotherapy Sales and Value (2011-2016)

8.1.1 Southeast Asia Chemotherapy Sales and Growth Rate (2011-2016)

8.1.2 Southeast Asia Chemotherapy Revenue and Growth Rate (2011-2016)

8.1.3 Southeast Asia Chemotherapy Sales Price Trend (2011-2016)

8.2 Southeast Asia Chemotherapy Sales and Market Share by Manufacturers

8.3 Southeast Asia Chemotherapy Sales and Market Share by Type

8.4 Southeast Asia Chemotherapy Sales and Market Share by Application

9 Global Chemotherapy Manufacturers Analysis

9.1 Pfizer Inc. (USA)

9.1.1 Company Basic Information, Manufacturing Base and Competitors

9.1.2 Chemotherapy Product Type, Application and Specification

9.1.2.1 Type I

9.1.2.2 Type II

9.1.3 Pfizer Inc. (USA) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)

9.1.4 Main Business/Business Overview

9.2 Abbott Laboratories (USA)

9.2.1 Company Basic Information, Manufacturing Base and Competitors

9.2.2 125 Product Type, Application and Specification

9.2.2.1 Type I

9.2.2.2 Type II

9.2.3 Abbott Laboratories (USA) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)

9.2.4 Main Business/Business Overview

9.3 Genentech Inc. (USA)

9.3.1 Company Basic Information, Manufacturing Base and Competitors

9.3.2 144 Product Type, Application and Specification

9.3.2.1 Type I

9.3.2.2 Type II

9.3.3 Genentech Inc. (USA) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)

9.3.4 Main Business/Business Overview

9.4 GlaxoSmithKline Plc (UK)

9.4.1 Company Basic Information, Manufacturing Base and Competitors

9.4.2 Aug Product Type, Application and Specification

9.4.2.1 Type I

9.4.2.2 Type II

9.4.3 GlaxoSmithKline Plc (UK) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)

9.4.4 Main Business/Business Overview

9.5 Immunomedics, Inc. (USA)

9.5.1 Company Basic Information, Manufacturing Base and Competitors

9.5.2 Product Type, Application and Specification

9.5.2.1 Type I

9.5.2.2 Type II

9.5.3 Immunomedics, Inc. (USA) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)

9.5.4 Main Business/Business Overview

9.6 Indevus Pharmaceuticals Inc. (USA)

9.6.1 Company Basic Information, Manufacturing Base and Competitors

9.6.2 Million USD Product Type, Application and Specification

9.6.2.1 Type I

9.6.2.2 Type II

9.6.3 Indevus Pharmaceuticals Inc. (USA) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)

9.6.4 Main Business/Business Overview

9.7 Novartis AG (Switzerland)

9.7.1 Company Basic Information, Manufacturing Base and Competitors

9.7.2 Pharma & Healthcare Product Type, Application and Specification

9.7.2.1 Type I

9.7.2.2 Type II

9.7.3 Novartis AG (Switzerland) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)

9.7.4 Main Business/Business Overview

9.8 OSI Pharmaceuticals, Inc. (USA)

9.8.1 Company Basic Information, Manufacturing Base and Competitors

9.8.2 Product Type, Application and Specification

9.8.2.1 Type I

9.8.2.2 Type II

9.8.3 OSI Pharmaceuticals, Inc. (USA) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)

9.8.4 Main Business/Business Overview

9.9 Paladin Labs Inc. (Canada)

9.9.1 Company Basic Information, Manufacturing Base and Competitors

9.9.2 Product Type, Application and Specification

9.9.2.1 Type I

9.9.2.2 Type II

9.9.3 Paladin Labs Inc. (Canada) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)

9.9.4 Main Business/Business Overview

9.10 ALZA Corporation (USA)

9.10.1 Company Basic Information, Manufacturing Base and Competitors

9.10.2 Product Type, Application and Specification

9.10.2.1 Type I

9.10.2.2 Type II

9.10.3 ALZA Corporation (USA) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)

9.10.4 Main Business/Business Overview

9.11 Amgen Inc. (USA)

9.12 AstraZeneca PLC (UK)

9.13 Medimmune, LLC (USA)

9.14 Bristol-Myers Squibb Company (USA)

9.15 Cell Genesys Inc. (USA)

9.16 Dendreon Corporation (USA)

9.17 EUSA Pharma, (USA) Inc. (USA)

9.18 F. Hoffmann-La Roche Ltd. (Switzerland)

9.19 Progenics Pharmaceuticals, Inc. (USA)

9.20 Sanofi-Aventis SA (France)

9.21 Spectrum Pharmaceuticals, Inc. (USA)

9.22 Takeda Pharmaceutical Company Limited (Japan)

10 Chemotherapy Maufacturing Cost Analysis

10.1 Chemotherapy Key Raw Materials Analysis

10.1.1 Key Raw Materials

10.1.2 Price Trend of Key Raw Materials

10.1.3 Key Suppliers of Raw Materials

10.1.4 Market Concentration Rate of Raw Materials

10.2 Proportion of Manufacturing Cost Structure

10.2.1 Raw Materials

10.2.2 Labor Cost

10.2.3 Manufacturing Process Analysis of Chemotherapy

11 Industrial Chain, Sourcing Strategy and Downstream Buyers

11.1 Chemotherapy Industrial Chain Analysis

11.2 Upstream Raw Materials Sourcing

11.3 Raw Materials Sources of Chemotherapy Major Manufacturers in 2015

11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders

12.1 Marketing Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.1.3 Marketing Channel Development Trend

12.2 Market Positioning

12.2.1 Pricing Strategy

12.2.2 Brand Strategy

12.2.3 Target Client

12.3 Distributors/Traders List

13 Market Effect Factors Analysis

13.1 Technology Progress/Risk

13.1.1 Substitutes Threat

13.1.2 Technology Progress in Related Industry

13.2 Consumer Needs/Customer Preference Change

13.3 Economic/Political Environmental Change

14 Global Chemotherapy Market Forecast (2016-2021)

14.1 Global Chemotherapy Sales, Revenue Forecast (2016-2021)

14.2 Global Chemotherapy Sales Forecast by Regions (2016-2021)

14.3 Global Chemotherapy Sales Forecast by Type (2016-2021)

14.4 Global Chemotherapy Sales Forecast by Application (2016-2021)

15 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

China Disclaimer

List of Tables and Figures

Figure Picture of Chemotherapy

Table Classification of Chemotherapy

Figure Global Sales Market Share of Chemotherapy by Type in 2015

Figure Type I Picture

Figure Type II Picture

Table Applications of Chemotherapy

Figure Global Sales Market Share of Chemotherapy by Application in 2015

Figure Application 1 Examples

Figure Application 2 Examples

Figure USA Chemotherapy Revenue and Growth Rate (2011-2021)

Figure China Chemotherapy Revenue and Growth Rate (2011-2021)

Figure Europe Chemotherapy Revenue and Growth Rate (2011-2021)

Figure Japan Chemotherapy Revenue and Growth Rate (2011-2021)

Figure India Chemotherapy Revenue and Growth Rate (2011-2021)

Figure Southeast Asia Chemotherapy Revenue and Growth Rate (2011-2021)

Figure Global Chemotherapy Sales and Growth Rate (2011-2021)

Figure Global Chemotherapy Revenue and Growth Rate (2011-2021)

Table Global Chemotherapy Sales of Key Manufacturers (2011-2016)

Table Global Chemotherapy Sales Share by Manufacturers (2011-2016)

Figure 2015 Chemotherapy Sales Share by Manufacturers

Figure 2016 Chemotherapy Sales Share by Manufacturers

Table Global Chemotherapy Revenue by Manufacturers (2011-2016)

Table Global Chemotherapy Revenue Share by Manufacturers (2011-2016)

Table 2015 Global Chemotherapy Revenue Share by Manufacturers

Table 2016 Global Chemotherapy Revenue Share by Manufacturers

Table Global Chemotherapy Sales and Market Share by Type (2011-2016)

Table Global Chemotherapy Sales Share by Type (2011-2016)

Figure Sales Market Share of Chemotherapy by Type (2011-2016)

Figure Global Chemotherapy Sales Growth Rate by Type (2011-2016)

Table Global Chemotherapy Revenue and Market Share by Type (2011-2016)

Table Global Chemotherapy Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Chemotherapy by Type (2011-2016)

Figure Global Chemotherapy Revenue Growth Rate by Type (2011-2016)

Table Global Chemotherapy Sales and Market Share by Regions (2011-2016)

Table Global Chemotherapy Sales Share by Regions (2011-2016)

Figure Sales Market Share of Chemotherapy by Regions (2011-2016)

Figure Global Chemotherapy Sales Growth Rate by Regions (2011-2016)

Table Global Chemotherapy Revenue and Market Share by Regions (2011-2016)

Table Global Chemotherapy Revenue Share by Regions (2011-2016)

Figure Revenue Market Share of Chemotherapy by Regions (2011-2016)

Figure Global Chemotherapy Revenue Growth Rate by Regions (2011-2016)

Table Global Chemotherapy Sales and Market Share by Application (2011-2016)

Table Global Chemotherapy Sales Share by Application (2011-2016)

Figure Sales Market Share of Chemotherapy by Application (2011-2016)

Figure Global Chemotherapy Sales Growth Rate by Application (2011-2016)

Figure USA Chemotherapy Sales and Growth Rate (2011-2016)

Figure USA Chemotherapy Revenue and Growth Rate (2011-2016)

Figure USA Chemotherapy Sales Price Trend (2011-2016)

Table USA Chemotherapy Sales by Manufacturers (2011-2016)

Table USA Chemotherapy Market Share by Manufacturers (2011-2016)

Table USA Chemotherapy Sales by Type (2011-2016)

Table USA Chemotherapy Market Share by Type (2011-2016)

Table USA Chemotherapy Sales by Application (2011-2016)

Table USA Chemotherapy Market Share by Application (2011-2016)

Figure China Chemotherapy Sales and Growth Rate (2011-2016)

Figure China Chemotherapy Revenue and Growth Rate (2011-2016)

Figure China Chemotherapy Sales Price Trend (2011-2016)

Table China Chemotherapy Sales by Manufacturers (2011-2016)

Table China Chemotherapy Market Share by Manufacturers (2011-2016)

Table China Chemotherapy Sales by Type (2011-2016)

Table China Chemotherapy Market Share by Type (2011-2016)

Table China Chemotherapy Sales by Application (2011-2016)

Table China Chemotherapy Market Share by Application (2011-2016)

Figure Europe Chemotherapy Sales and Growth Rate (2011-2016)

Figure Europe Chemotherapy Revenue and Growth Rate (2011-2016)

Figure Europe Chemotherapy Sales Price Trend (2011-2016)

Table Europe Chemotherapy Sales by Manufacturers (2011-2016)

Table Europe Chemotherapy Market Share by Manufacturers (2011-2016)

Table Europe Chemotherapy Sales by Type (2011-2016)

Table Europe Chemotherapy Market Share by Type (2011-2016)

Table Europe Chemotherapy Sales by Application (2011-2016)

Table Europe Chemotherapy Market Share by Application (2011-2016)

Figure Japan Chemotherapy Sales and Growth Rate (2011-2016)

Figure Japan Chemotherapy Revenue and Growth Rate (2011-2016)

Figure Japan Chemotherapy Sales Price Trend (2011-2016)

Table Japan Chemotherapy Sales by Manufacturers (2011-2016)

Table Japan Chemotherapy Market Share by Manufacturers (2011-2016)

Table Japan Chemotherapy Sales by Type (2011-2016)

Table Japan Chemotherapy Market Share by Type (2011-2016)

Table Japan Chemotherapy Sales by Application (2011-2016)

Table Japan Chemotherapy Market Share by Application (2011-2016)

Figure India Chemotherapy Sales and Growth Rate (2011-2016)

Figure India Chemotherapy Revenue and Growth Rate (2011-2016)

Figure India Chemotherapy Sales Price Trend (2011-2016)

Table India Chemotherapy Sales by Manufacturers (2011-2016)

Table India Chemotherapy Market Share by Manufacturers (2011-2016)

Table India Chemotherapy Sales by Type (2011-2016)

Table India Chemotherapy Market Share by Type (2011-2016)

Table India Chemotherapy Sales by Application (2011-2016)

Table India Chemotherapy Market Share by Application (2011-2016)

Figure Southeast Asia Chemotherapy Sales and Growth Rate (2011-2016)

Figure Southeast Asia Chemotherapy Revenue and Growth Rate (2011-2016)

Figure Southeast Asia Chemotherapy Sales Price Trend (2011-2016)

Table Southeast Asia Chemotherapy Sales by Manufacturers (2011-2016)

Table Southeast Asia Chemotherapy Market Share by Manufacturers (2011-2016)

Table Southeast Asia Chemotherapy Sales by Type (2011-2016)

Table Southeast Asia Chemotherapy Market Share by Type (2011-2016)

Table Southeast Asia Chemotherapy Sales by Application (2011-2016)

Table Southeast Asia Chemotherapy Market Share by Application (2011-2016)

Table Pfizer Inc. (USA) Basic Information List

Table Pfizer Inc. (USA) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Pfizer Inc. (USA) Chemotherapy Global Market Share (2011-2016)

Table Abbott Laboratories (USA) Basic Information List

Table Abbott Laboratories (USA) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Abbott Laboratories (USA) Chemotherapy Global Market Share (2011-2016)

Table Genentech Inc. (USA) Basic Information List

Table Genentech Inc. (USA) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Genentech Inc. (USA) Chemotherapy Global Market Share (2011-2016)

Table GlaxoSmithKline Plc (UK) Basic Information List

Table GlaxoSmithKline Plc (UK) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)

Figure GlaxoSmithKline Plc (UK) Chemotherapy Global Market Share (2011-2016)

Table Immunomedics, Inc. (USA) Basic Information List

Table Immunomedics, Inc. (USA) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Immunomedics, Inc. (USA) Chemotherapy Global Market Share (2011-2016)

Table Indevus Pharmaceuticals Inc. (USA) Basic Information List

Table Indevus Pharmaceuticals Inc. (USA) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Indevus Pharmaceuticals Inc. (USA) Chemotherapy Global Market Share (2011-2016)

Table Novartis AG (Switzerland) Basic Information List

Table Novartis AG (Switzerland) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Novartis AG (Switzerland) Chemotherapy Global Market Share (2011-2016)

Table OSI Pharmaceuticals, Inc. (USA) Basic Information List

Table OSI Pharmaceuticals, Inc. (USA) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)

Figure OSI Pharmaceuticals, Inc. (USA) Chemotherapy Global Market Share (2011-2016)

Table Paladin Labs Inc. (Canada) Basic Information List

Table Paladin Labs Inc. (Canada) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Paladin Labs Inc. (Canada) Chemotherapy Global Market Share (2011-2016)

Table ALZA Corporation (USA) Basic Information List

Table ALZA Corporation (USA) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)

Figure ALZA Corporation (USA) Chemotherapy Global Market Share (2011-2016)

Table Amgen Inc. (USA) Basic Information List

Table Amgen Inc. (USA) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Amgen Inc. (USA) Chemotherapy Global Market Share (2011-2016)

Table AstraZeneca PLC (UK) Basic Information List

Table AstraZeneca PLC (UK) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)

Figure AstraZeneca PLC (UK) Chemotherapy Global Market Share (2011-2016)

Table Medimmune, LLC (USA) Basic Information List

Table Medimmune, LLC (USA) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Medimmune, LLC (USA) Chemotherapy Global Market Share (2011-2016)

Table Bristol-Myers Squibb Company (USA) Basic Information List

Table Bristol-Myers Squibb Company (USA) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Bristol-Myers Squibb Company (USA) Chemotherapy Global Market Share (2011-2016)

Table Cell Genesys Inc. (USA) Basic Information List

Table Cell Genesys Inc. (USA) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Cell Genesys Inc. (USA) Chemotherapy Global Market Share (2011-2016)

Table Dendreon Corporation (USA) Basic Information List

Table Dendreon Corporation (USA) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Dendreon Corporation (USA) Chemotherapy Global Market Share (2011-2016)

Table EUSA Pharma, (USA) Inc. (USA) Basic Information List

Table EUSA Pharma, (USA) Inc. (USA) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)

Figure EUSA Pharma, (USA) Inc. (USA) Chemotherapy Global Market Share (2011-2016)

Table F. Hoffmann-La Roche Ltd. (Switzerland) Basic Information List

Table F. Hoffmann-La Roche Ltd. (Switzerland) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)

Figure F. Hoffmann-La Roche Ltd. (Switzerland) Chemotherapy Global Market Share (2011-2016)

Table Progenics Pharmaceuticals, Inc. (USA) Basic Information List

Table Progenics Pharmaceuticals, Inc. (USA) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Progenics Pharmaceuticals, Inc. (USA) Chemotherapy Global Market Share (2011-2016)

Table Sanofi-Aventis SA (France) Basic Information List

Table Sanofi-Aventis SA (France) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Sanofi-Aventis SA (France) Chemotherapy Global Market Share (2011-2016)

Table Spectrum Pharmaceuticals, Inc. (USA) Basic Information List

Table Spectrum Pharmaceuticals, Inc. (USA) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Spectrum Pharmaceuticals, Inc. (USA) Chemotherapy Global Market Share (2011-2016)

Table Takeda Pharmaceutical Company Limited (Japan) Basic Information List

Table Takeda Pharmaceutical Company Limited (Japan) Chemotherapy Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Takeda Pharmaceutical Company Limited (Japan) Chemotherapy Global Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Chemotherapy

Figure Manufacturing Process Analysis of Chemotherapy

Figure Chemotherapy Industrial Chain Analysis

Table Raw Materials Sources of Chemotherapy Major Manufacturers in 2015

Table Major Buyers of Chemotherapy

Table Distributors/Traders List

Figure Global Chemotherapy Sales and Growth Rate Forecast (2016-2021)

Figure Global Chemotherapy Revenue and Growth Rate Forecast (2016-2021)

Table Global Chemotherapy Sales Forecast by Regions (2016-2021)

Table Global Chemotherapy Sales Forecast by Type (2016-2021)

Table Global Chemotherapy Sales Forecast by Application (2016-2021)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Biomaterials Market by Type (Metallic, Polymeric, Ceramic and Natural) and Application (Cardiovascular, Dental, Orthopedic, Wound Healing, Plastic, Surgery, Ophthalmology, Tissue Engineering, Neurological Disorders and Drug-Delivery Systems) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

Biomaterials are materials of either synthetic or natural origin that are used for interaction with biological systems for medical purposes such as treating or repairing damage tissues. They are used in joint replacements, plastic surgeries, drug delivery devi...

  • Publish Date: September 1, 2016
  • $5370
DNA Sequencing Market by Product (Consumable, Instrument, and Service) Application (Biomarkers and Cancer, Diagnostics, Reproductive Health, Personalized Medicine, Forensics, and Others), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real-time Sequencing, Chain Termination Sequencing, and Nanopore Sequencing), and End User (Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, and Hospitals & Clinics): Global Opportunity Analysis and Industry Forecast, 2017 - 2025

The global DNA sequencing market was estimated to be $6,243 million in 2017 and is projected to reach $25,470 million in 2025 growing with a CAGR of 19% from 2018 to 2025. DNA sequencing is a type of technology in which several DNA strands can be sequenced through massive parallelization. The DNA sequencing contains both Sanger’s method of sequencing and non-Sanger’s methods of sequencing. ...

  • Publish Date: May 24, 2017
  • $5370